XML 23 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating activities:    
Net income $ 61,549 $ 31,136
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 100,479 108,544
Debt premium and discount amortization (4,066) (5,048)
Deferred financing cost amortization 1,937 2,048
Above- and below-market lease intangible amortization (11,018) (13,530)
Provisions for impairment 0 807
Equity based compensation (1,582) 12,951
Other 231 49
Gain on extinguishment of debt, net 0 (297)
Changes in operating assets and liabilities:    
Restricted cash (2,113) (6,845)
Receivables 10,589 3,675
Deferred charges and prepaid expenses (5,310) (2,608)
Other assets 84 (268)
Accounts payable, accrued expenses and other liabilities (36,778) (17,677)
Net cash provided by operating activities 114,002 112,937
Investing activities:    
Improvements to and investments in real estate assets (36,340) (40,411)
Proceeds from sales of real estate assets 0 9,918
Change in restricted cash attributable to investing activities (636) (1,678)
Purchase of marketable securities (6,893) (4,200)
Proceeds from sale of marketable securities 6,810 4,499
Net cash used in investing activities (37,059) (31,872)
Financing activities:    
Repayment of debt obligations and financing liabilities (4,740) (158,568)
Repayment of borrowings under unsecured revolving credit facility 0 (682,475)
Proceeds from borrowings under unsecured revolving credit facility 40,000 163,000
Proceeds from unsecured term loan and notes 0 695,156
Deferred financing costs 0 (1,899)
Distributions to common stockholders (73,447) (66,750)
Distributions to non-controlling interests (1,297) (21,611)
Repurchase of common shares in conjunction with equity award plans (1,165) (329)
Net cash used in financing activities (40,649) (73,476)
Change in cash and cash equivalents 36,294 7,589
Cash and cash equivalents at beginning of period 69,528 60,595
Cash and cash equivalents at end of period 105,822 68,184
Supplemental disclosure of cash flow information:    
Cash paid for interest, net of amount capitalized of $587 and $656 68,088 61,355
Brixmor Operating Partnership LP [Member]    
Operating activities:    
Net income 61,549 31,136
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 100,479 108,544
Debt premium and discount amortization (4,066) (5,048)
Deferred financing cost amortization 1,937 2,048
Above- and below-market lease intangible amortization (11,018) (13,530)
Provisions for impairment 0 807
Equity based compensation (1,582) 12,951
Other 231 49
Gain on extinguishment of debt, net 0 (297)
Changes in operating assets and liabilities:    
Restricted cash (2,113) (6,845)
Receivables 10,589 3,675
Deferred charges and prepaid expenses (5,310) (2,608)
Other assets 84 (268)
Accounts payable, accrued expenses and other liabilities (36,780) (17,670)
Net cash provided by operating activities 114,000 112,944
Investing activities:    
Improvements to and investments in real estate assets (36,340) (40,411)
Proceeds from sales of real estate assets 0 9,918
Change in restricted cash attributable to investing activities (636) (1,675)
Purchase of marketable securities (6,884) (4,200)
Proceeds from sale of marketable securities 6,810 4,499
Net cash used in investing activities (37,050) (31,869)
Financing activities:    
Repayment of debt obligations and financing liabilities (4,740) (158,568)
Repayment of borrowings under unsecured revolving credit facility 0 (682,475)
Proceeds from borrowings under unsecured revolving credit facility 40,000 163,000
Proceeds from unsecured term loan and notes 0 695,156
Deferred financing costs 0 (1,899)
Partner distributions (75,930) (68,722)
Distributions to non-controlling interests 0 (19,870)
Net cash used in financing activities (40,670) (73,378)
Change in cash and cash equivalents 36,280 7,697
Cash and cash equivalents at beginning of period 69,506 60,450
Cash and cash equivalents at end of period $ 105,786 $ 68,147